Bristol Myers Squibb CELG-RI
NYSE CELG-RI
$0.11 +0.02 (+19.09%)
As of: Aug 21, 2026 · 2:40 PM EDT

Bristol Myers Squibb (CELG-RI) Debt Ratio (2009 - 2026)

Bristol Myers Squibb (CELG-RI) posted quarterly Debt Ratio of 0.5 for Q2 2026, down 11.64% year-over-year from 0.57 in Q2 2025, and down 6.76% quarter-over-quarter from 0.54 in Q1 2026.

Bristol Myers Squibb (CELG-RI) Debt Ratio (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (CELG-RI) has reported Debt Ratio for 18 consecutive years, with 0.5 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Debt Ratio fell 11.64% year-over-year to 0.5; the TTM figure through Jun 2026 stood at 0.5 (down 11.64% YoY), while the FY2025 annual figure was 0.52, down 5.92% from the prior year.
  • Debt Ratio eased to 0.5 in Q2 2026 per CELG-RI's latest filing, from 0.54 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.59 in Q1 2024 and bottomed at 0.42 in Q3 2022.
  • Historically, Debt Ratio has averaged 0.51 across 5 years, with a median of 0.52 in 2022.
  • Annual changes were most pronounced in 2023 — Debt Ratio fell 16.19% — and 2024, when it jumped 39.06%.
  • Bristol Myers Squibb's Debt Ratio stood at 0.45 in 2022, then grew by 0.4% to 0.45 in 2023, then grew by 24.04% to 0.56 in 2024, then retreated by 5.92% to 0.52 in 2025, then slipped by 4.24% to 0.5 in 2026.
  • Business Quant data shows CELG-RI's Debt Ratio at 0.5 in Q2 2026, 0.54 in Q1 2026, and 0.52 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 0.24
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 0.52
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 0.42
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 0.08
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 0.25
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 0.66
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 0.58
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 0.31
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -0.31
10 Bristol Myers Squibb 224.21 Mn -10.84 Bn 9.25 Bn 0.50

Historic Data

Download Data
DateValue
Jun 30, 2026 0.50
Mar 31, 2026 0.54
Dec 31, 2025 0.50
Sep 30, 2025 0.51
Jun 30, 2025 0.57
Mar 31, 2025 0.54
Dec 31, 2024 0.56
Sep 30, 2024 0.53
Jun 30, 2024 0.59
Mar 31, 2024 0.56
Dec 31, 2023 0.45
Sep 30, 2023 0.41
Jun 30, 2023 0.40
Mar 31, 2023 0.40
Dec 31, 2022 0.45
Sep 30, 2022 0.42
Jun 30, 2022 0.42
Mar 31, 2022 0.51
Dec 31, 2021 0.41
Sep 30, 2021 0.45